VIATRIS INC (VTRS) Fundamental Analysis & Valuation

NASDAQ:VTRS • US92556V1061

13.8 USD
-0.17 (-1.22%)
At close: Mar 12, 2026
13.8 USD
0 (0%)
After Hours: 3/12/2026, 8:15:45 PM

This VTRS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, VTRS scores 4 out of 10 in our fundamental rating. VTRS was compared to 193 industry peers in the Pharmaceuticals industry. While VTRS is still in line with the averages on profitability rating, there are concerns on its financial health. VTRS is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. VTRS Profitability Analysis

1.1 Basic Checks

  • VTRS had positive earnings in the past year.
  • In the past year VTRS had a positive cash flow from operations.
  • In multiple years VTRS reported negative net income over the last 5 years.
  • Each year in the past 5 years VTRS had a positive operating cash flow.
VTRS Yearly Net Income VS EBIT VS OCF VS FCFVTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

  • With a decent Return On Assets value of -9.45%, VTRS is doing good in the industry, outperforming 68.91% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -23.89%, VTRS is in the better half of the industry, outperforming 66.32% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.44%, VTRS belongs to the top of the industry, outperforming 81.35% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for VTRS is significantly below the industry average of 13.21%.
Industry RankSector Rank
ROA -9.45%
ROE -23.89%
ROIC 3.44%
ROA(3y)-3.62%
ROA(5y)-1.8%
ROE(3y)-9.01%
ROE(5y)-4.67%
ROIC(3y)3.51%
ROIC(5y)3.8%
VTRS Yearly ROA, ROE, ROICVTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • VTRS has a better Operating Margin (9.17%) than 81.87% of its industry peers.
  • In the last couple of years the Operating Margin of VTRS has declined.
  • VTRS has a Gross Margin of 39.55%. This is in the better half of the industry: VTRS outperforms 62.69% of its industry peers.
  • VTRS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.17%
PM (TTM) N/A
GM 39.55%
OM growth 3Y-18.61%
OM growth 5Y-5.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5Y0.79%
VTRS Yearly Profit, Operating, Gross MarginsVTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

3

2. VTRS Health Analysis

2.1 Basic Checks

  • VTRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • VTRS has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for VTRS has been reduced compared to 5 years ago.
  • VTRS has a worse debt/assets ratio than last year.
VTRS Yearly Shares OutstandingVTRS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
VTRS Yearly Total Debt VS Total AssetsVTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • Based on the Altman-Z score of 1.00, we must say that VTRS is in the distress zone and has some risk of bankruptcy.
  • VTRS has a Altman-Z score (1.00) which is in line with its industry peers.
  • VTRS has a debt to FCF ratio of 7.79. This is a slightly negative value and a sign of low solvency as VTRS would need 7.79 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 7.79, VTRS belongs to the best of the industry, outperforming 80.83% of the companies in the same industry.
  • VTRS has a Debt/Equity ratio of 0.85. This is a neutral value indicating VTRS is somewhat dependend on debt financing.
  • The Debt to Equity ratio of VTRS (0.85) is worse than 68.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 7.79
Altman-Z 1
ROIC/WACC0.42
WACC8.22%
VTRS Yearly LT Debt VS Equity VS FCFVTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • VTRS has a Current Ratio of 1.38. This is a normal value and indicates that VTRS is financially healthy and should not expect problems in meeting its short term obligations.
  • VTRS has a worse Current ratio (1.38) than 72.54% of its industry peers.
  • A Quick Ratio of 0.82 indicates that VTRS may have some problems paying its short term obligations.
  • VTRS's Quick ratio of 0.82 is on the low side compared to the rest of the industry. VTRS is outperformed by 79.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.82
VTRS Yearly Current Assets VS Current LiabilitesVTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

3

3. VTRS Growth Analysis

3.1 Past

  • The earnings per share for VTRS have decreased strongly by -10.94% in the last year.
  • Measured over the past years, VTRS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.71% on average per year.
  • VTRS shows a decrease in Revenue. In the last year, the revenue decreased by -2.98%.
  • VTRS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.66% yearly.
EPS 1Y (TTM)-10.94%
EPS 3Y-11.02%
EPS 5Y-11.71%
EPS Q2Q%5.56%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y-4.2%
Revenue growth 5Y3.66%
Sales Q2Q%4.97%

3.2 Future

  • Based on estimates for the next years, VTRS will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.43% on average per year.
  • Based on estimates for the next years, VTRS will show a small growth in Revenue. The Revenue will grow by 3.87% on average per year.
EPS Next Y6.3%
EPS Next 2Y8.73%
EPS Next 3Y12.45%
EPS Next 5Y16.43%
Revenue Next Year2.59%
Revenue Next 2Y2.23%
Revenue Next 3Y2.24%
Revenue Next 5Y3.87%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
VTRS Yearly Revenue VS EstimatesVTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
VTRS Yearly EPS VS EstimatesVTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

8

4. VTRS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 5.85 indicates a rather cheap valuation of VTRS.
  • Based on the Price/Earnings ratio, VTRS is valued cheaply inside the industry as 94.82% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 25.71, VTRS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 5.50, the valuation of VTRS can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 94.30% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of VTRS to the average of the S&P500 Index (23.82), we can say VTRS is valued rather cheaply.
Industry RankSector Rank
PE 5.85
Fwd PE 5.5
VTRS Price Earnings VS Forward Price EarningsVTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VTRS is valued cheaper than 93.26% of the companies in the same industry.
  • 92.75% of the companies in the same industry are more expensive than VTRS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.59
EV/EBITDA 7.05
VTRS Per share dataVTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as VTRS's earnings are expected to grow with 12.45% in the coming years.
PEG (NY)0.93
PEG (5Y)N/A
EPS Next 2Y8.73%
EPS Next 3Y12.45%

5

5. VTRS Dividend Analysis

5.1 Amount

  • VTRS has a Yearly Dividend Yield of 3.67%.
  • VTRS's Dividend Yield is rather good when compared to the industry average which is at 0.71. VTRS pays more dividend than 95.85% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, VTRS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

  • VTRS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
VTRS Yearly Dividends per shareVTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • VTRS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-15.97%
EPS Next 2Y8.73%
EPS Next 3Y12.45%
VTRS Yearly Income VS Free CF VS DividendVTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

VTRS Fundamentals: All Metrics, Ratios and Statistics

VIATRIS INC

NASDAQ:VTRS (3/12/2026, 8:15:45 PM)

After market: 13.8 0 (0%)

13.8

-0.17 (-1.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners87.39%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change19.04%
Market Cap15.89B
Revenue(TTM)14.30B
Net Income(TTM)-3.51B
Analysts76.67
Price Target14.17 (2.68%)
Short Float %2.31%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.97%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-09
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.32%
Min EPS beat(2)4.82%
Max EPS beat(2)5.83%
EPS beat(4)4
Avg EPS beat(4)5.04%
Min EPS beat(4)0.14%
Max EPS beat(4)9.36%
EPS beat(8)5
Avg EPS beat(8)2.36%
EPS beat(12)8
Avg EPS beat(12)2.58%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)2
Avg Revenue beat(2)2.47%
Min Revenue beat(2)2.14%
Max Revenue beat(2)2.79%
Revenue beat(4)3
Avg Revenue beat(4)1.21%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)2.79%
Revenue beat(8)3
Avg Revenue beat(8)-0.55%
Revenue beat(12)3
Avg Revenue beat(12)-1.29%
Revenue beat(16)3
Avg Revenue beat(16)-1.86%
PT rev (1m)5.83%
PT rev (3m)14.42%
EPS NQ rev (1m)-7.16%
EPS NQ rev (3m)-10.04%
EPS NY rev (1m)-0.81%
EPS NY rev (3m)-0.51%
Revenue NQ rev (1m)1.07%
Revenue NQ rev (3m)1.07%
Revenue NY rev (1m)1.27%
Revenue NY rev (3m)1.41%
Valuation
Industry RankSector Rank
PE 5.85
Fwd PE 5.5
P/S 1.11
P/FCF 8.59
P/OCF 6.86
P/B 1.08
P/tB N/A
EV/EBITDA 7.05
EPS(TTM)2.36
EY17.1%
EPS(NY)2.51
Fwd EY18.18%
FCF(TTM)1.61
FCFY11.65%
OCF(TTM)2.01
OCFY14.58%
SpS12.42
BVpS12.78
TBVpS-6.21
PEG (NY)0.93
PEG (5Y)N/A
Graham Number26.05
Profitability
Industry RankSector Rank
ROA -9.45%
ROE -23.89%
ROCE 4.36%
ROIC 3.44%
ROICexc 3.61%
ROICexgc 15.21%
OM 9.17%
PM (TTM) N/A
GM 39.55%
FCFM 12.94%
ROA(3y)-3.62%
ROA(5y)-1.8%
ROE(3y)-9.01%
ROE(5y)-4.67%
ROIC(3y)3.51%
ROIC(5y)3.8%
ROICexc(3y)3.63%
ROICexc(5y)3.92%
ROICexgc(3y)14.75%
ROICexgc(5y)18.05%
ROCE(3y)4.44%
ROCE(5y)4.84%
ROICexgc growth 3Y-14.75%
ROICexgc growth 5Y3.75%
ROICexc growth 3Y-11.49%
ROICexc growth 5Y9.86%
OM growth 3Y-18.61%
OM growth 5Y-5.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 7.79
Debt/EBITDA 3.04
Cap/Depr 16.62%
Cap/Sales 3.25%
Interest Coverage 2.66
Cash Conversion 56.35%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.82
Altman-Z 1
F-Score5
WACC8.22%
ROIC/WACC0.42
Cap/Depr(3y)15.31%
Cap/Depr(5y)14.37%
Cap/Sales(3y)2.89%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.94%
EPS 3Y-11.02%
EPS 5Y-11.71%
EPS Q2Q%5.56%
EPS Next Y6.3%
EPS Next 2Y8.73%
EPS Next 3Y12.45%
EPS Next 5Y16.43%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y-4.2%
Revenue growth 5Y3.66%
Sales Q2Q%4.97%
Revenue Next Year2.59%
Revenue Next 2Y2.23%
Revenue Next 3Y2.24%
Revenue Next 5Y3.87%
EBIT growth 1Y-26.08%
EBIT growth 3Y-22.03%
EBIT growth 5Y-2.16%
EBIT Next Year14.48%
EBIT Next 3Y9.13%
EBIT Next 5Y9.64%
FCF growth 1Y-5.38%
FCF growth 3Y-9.65%
FCF growth 5Y27.44%
OCF growth 1Y0.56%
OCF growth 3Y-7.78%
OCF growth 5Y13.46%

VIATRIS INC / VTRS FAQ

What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to VTRS.


What is the valuation status for VTRS stock?

ChartMill assigns a valuation rating of 8 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.


What is the profitability of VTRS stock?

VIATRIS INC (VTRS) has a profitability rating of 5 / 10.


What is the valuation of VIATRIS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for VIATRIS INC (VTRS) is 5.85 and the Price/Book (PB) ratio is 1.08.


How sustainable is the dividend of VIATRIS INC (VTRS) stock?

The dividend rating of VIATRIS INC (VTRS) is 5 / 10 and the dividend payout ratio is -15.97%.